Related Experiment Video
Updated: Jun 16, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Impact of socioeconomic status on cancer care in Southeast Texas: a retrospective population-based cohort study
Junaid Anwar1, Jacob Thompson2, Zouina Sarfraz3
1Department of Medicine, Baptist Hospitals of Southeast Texas, Beaumont, Texas, USA.
Background:
Gastrointestinal (GI) cancers are the third leading cause of cancer-related mortality worldwide. Disparities in healthcare frequently stem from variations in socioeconomic status (SES). This study investigated the influence of socioeconomic factors such as gender, race, age, and geography on time to treatment initiation (TTI) and survival outcomes.
Methods:
The study analyzed SES data, including age, race, geography, and insurance status, from GI cancer patients treated at Baptist Hospitals of Southeast Texas (BHSET) from 2012 to 2017. Logistic regression was performed for risk association. The primary outcomes were survival time and TTI.
Results:
Of 517 GI cancer patients, 359 had colorectal cancer. African Americans had higher treatment delays (odds ratio [OR]: 5.89, confidence interval [CI]: 4.02-8.62) than Caucasians (OR: 0.16, CI: 0.11-0.23). Patients >80 years had poorer survival (OR: 2.91, CI: 1.80-4.72) than younger ones. Those living 30 + miles from BHSET had longer TTI (OR: 1.85, CI: 1.19-2.87), especially within the colorectal cancer cohort (OR: 2.20, CI: 1.29-3.74). Medicare Advantage was linked to longer TTI (OR: 1.50, CI: 1.01-2.23). Medicare patients without supplemental insurance had lower survival overall (OR: 1.79, CI: 1.05-3.06) and among colorectal cancer patients (OR: 2.13, CI: 1.14-3.98).
Conclusion:
Addressing SES disparities and implementing targeted interventions is imperative to ensure equitable access to timely and effective cancer care.
Related Concept Videos
Cancer Survival Analysis
Longitudinal Research
Statistical Methods for Analyzing Epidemiological Data
Comparing the Survival Analysis of Two or More Groups
Targeted Cancer Therapies
There are several types of targeted therapies against...
Kaplan-Meier Approach

